---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-081994"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:40:57.672853+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Journey Medical grants 300k RSUs to CEO, 150k RSUs to CFO

## Summary
- CEO Claude Maraoui received 300,000 RSUs; CFO Ernest De Paolantonio received 150,000 RSUs.
- RSUs vest in four equal annual installments beginning on July 21, 2023.
- Grants approved by Board on July 21, 2022 under the 2015 Stock Plan.
- Unvested RSUs subject to forfeiture upon termination; full vesting upon Change of Control.

## SEC filing metadata
- accession: 0001104659-22-081994
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465922081994/0001104659-22-081994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465922081994/tm2221474d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-081994
- JSON: https://secwatch.observer/filing/0001104659-22-081994.json
- Plain text: https://secwatch.observer/filing/0001104659-22-081994.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.